Liraglutide modulates adipokine expression during adipogenesis, ameliorating obesity, and polycystic ovary syndrome in mice
ConclusionThis study suggests that adiponectin may act as a link between metabolic disorders and PCOS and that liraglutide might be a promising therapeutic agent for the treatment of PCOS in addition to obesity and insulin resistance.
Source: Endocrine - Category: Endocrinology Source Type: research
More News: Eating Disorders & Weight Management | Endocrinology | Insulin | Obesity | Ovaries | Polycystic Ovary Syndrome | Study | Victoza